Beam Therapeutics

+$1.63 (+1.80%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.

CEO

John Evans

Employees

181

Headquarters

Cambridge, Massachusetts

Founded

2017

BEAM Key Statistics

Market Cap

5.76B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

521.55K

High Today

$93.85

Low Today

$89.33

Open Price

$89.75

Volume

475.10K

52 Week High

$138.52

52 Week Low

$18.76

Analyst Ratings

56%

of 9 ratings

Buy

55.6%

Hold

44.4%

Sell

BEAM Earnings

-$3.35

-$2.23

-$1.12

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 11, Pre-Market